Aviva’s Aehr Test Systems AEHR Stock Holding History

Aviva’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-53,697	Closed	-$600K	–	884
2024 Q2	$600K	Buy	53,697 +9,202	+21%	+$107K	﹤0.01%	786
2024 Q1	$552K	Buy	44,495 +20,961	+89%	+$349K	﹤0.01%	857
2023 Q4	$624K	Buy	+23,534	New	+$686K	﹤0.01%	827

Other funds holding AEHR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Aviva's AEHR Position: Q3 2024 in Review

Aviva sold out of Aehr Test Systems (AEHR) in Q3 2024, closing a stake of 53,697 shares — an estimated $600K sold.

Aviva first reported a position in AEHR in Q4 2023 and held it in 3 quarters. The position peaked at $624K in Q4 2023. 126 funds tracked by Wall St. Rank hold AEHR as of Q3 2024.

Aviva reported no remaining Aehr Test Systems position as of Q3 2024 after selling out during the quarter.
Aviva sold 53,697 Aehr Test Systems shares in Q3 2024, an estimated $600K.
Aviva first reported a position in Aehr Test Systems in Q4 2023 and held it in 3 quarters.
Aviva's Aehr Test Systems position peaked at $624K in Q4 2023.
126 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2024.

Based on Aviva's 13F filing for Q3 2024, filed 14 Nov 2024.